- Osteoarthritis is mostly wear and local inflammation; rheumatoid arthritis is the immune system misfiring.
- Wharton’s jelly cells send signals that calm inflammation and support the joint’s own repair.
- Trials have shown less pain and better daily function.
Arthritis has a way of setting the schedule. It decides how long you can stand at the stove, whether you take the stairs, and how you feel on a cold morning before the first coffee.
If the usual options have stopped helping, you have probably read about stem cells from the umbilical cord. Here is what they are, how they may help the two most common kinds of arthritis, and what the studies actually found.
Which arthritis is this about?
Osteoarthritis is the common one. The cartilage that cushions the joint thins out, and the lining of the joint gets inflamed. Knees, hips, hands and shoulders are the usual suspects.
Rheumatoid arthritis is different. The immune system attacks the lining of many joints at once, often the small joints of the hands and feet. One is a local problem; the other is a whole-body one.
What is Wharton’s jelly, and why use it?
It is the soft, gel-like tissue that protects the blood vessels inside the umbilical cord. It is rich in mesenchymal stem cells, and after a healthy birth the cord is usually thrown away.
These cells come from very young tissue and grow well in the lab. For you, that means no procedure to harvest cells from your own body. Stem Cells Colombia uses only Wharton’s jelly cells, never bone marrow or fat.
How might the cells help an arthritic joint?
Think of an inflamed joint as a room where the smoke alarm won’t stop ringing. The cells help switch off the alarm so the joint’s own cells can get back to maintenance.
- They calm inflammation by releasing signals that turn down the chemicals behind pain and swelling.
- They support repair with growth factors that help the tissue around the cartilage.
- They rebalance the immune response, which matters most in rheumatoid arthritis.
What have the studies found?
In knee osteoarthritis, a randomized trial compared umbilical cord cells with hyaluronic acid. At one year, patients who got two rounds of cells had less pain than those in the hyaluronic acid group, with no serious side effects.
A large review of 28 randomized trials found improvements in pain and daily function.
In rheumatoid arthritis, a study giving umbilical cord cells by IV alongside usual medicines reported lower inflammation markers and disease scores at one and three years. A 2020 systematic review of in vivo studies in patients with rheumatoid arthritis found the treatment safe and well tolerated, with improvements in symptoms and lower inflammatory markers.
Who could benefit most?
For osteoarthritis, people with mild to moderate joint damage usually have the most to gain. A specialist reviews your imaging first, so your plan is designed for your joint.
For rheumatoid arthritis, the goal is to work alongside your rheumatologist, not replace your medicines. Every IV protocol starts with cancer markers, for your safety.
- Know which arthritis you have; the approach for one joint and for the whole body is different.
- Send recent X-rays or an MRI; the stage of the joint shapes your plan.
- Send your imaging or labs on WhatsApp for a free evaluation, with your plan and price in writing and no commitment.
There are several randomized trials of mesenchymal cells in knee osteoarthritis, including one with umbilical cord cells. Together they point to improvements in pain and function. For rheumatoid arthritis, studies with umbilical cord cells are encouraging on safety and inflammation, with lower disease scores, and research is growing.
- Umbilical Cord-Derived Mesenchymal Stromal Cells (MSCs) for Knee Osteoarthritis: Repeated MSC Dosing Is Superior to a Single MSC Dose and to Hyaluronic Acid in a Controlled Randomized Phase I/II Trial · Stem Cells Translational Medicine, 2019
- Efficacy and safety of intra-articular mesenchymal stem cell-based therapies in knee osteoarthritis: A systematic review and meta-analysis of randomized controlled trials · Clinical Rheumatology, 2026
- Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cell Therapy for Rheumatoid Arthritis Patients: A Prospective Phase I/II Study · Drug Design, Development and Therapy, 2019
- Therapeutic Potential of Mesenchymal Stromal Stem Cells in Rheumatoid Arthritis: a Systematic Review of In Vivo Studies · Stem Cell Reviews and Reports, 2020
Questions
Can stem cells help both osteoarthritis and rheumatoid arthritis?
They are studied for both. In osteoarthritis the cells go into the joint; in rheumatoid arthritis an intravenous protocol aims at the immune system. Your specialist tells you which fits your case.
Will I need to stop my arthritis medicines?
No. Keep taking what your doctor prescribed. Any change is decided with your own rheumatologist.
When might I notice a change?
Every body responds at its own pace; improvement is usually expected at 4–6 months, and studies measure results up to a year, because the cells work on inflammation gradually.
How do you make sure it is safe for me?
Every IV protocol starts with cancer markers, for your safety, and a specialist reviews your full history first.
Is stem cell therapy approved by the FDA?
Stem cell therapy is not approved by the FDA, but in Colombia it is legal.